Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03993873
Title Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Turning Point Therapeutics, Inc.
Indications

lung non-small cell carcinoma

stomach cancer

gastroesophageal junction adenocarcinoma

hepatocellular carcinoma

Advanced Solid Tumor

Therapies

TPX-0022

Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Additional content available in CKB BOOST